Pharmaceutical Company
Active 2018–2026. The register lists this client once for every firm that files on its behalf; all 5 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | SPLITOAK STRATEGIES LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2026 | FTI GOVERNMENT AFFAIRS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | |
| 2026 | CHIESI USA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$280,000 | |
| 2026 | SPLITOAK STRATEGIES LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | |
| 2026 | FTI GOVERNMENT AFFAIRS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | |
| 2026 | CHIESI USA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$280,000 | |
| 2026 | SPLITOAK STRATEGIES LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2026 | FTI GOVERNMENT AFFAIRS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2026 | CHIESI USA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$330,000 | |
| 2025 | FTI GOVERNMENT AFFAIRS |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— |
| Firm | Filings | Amount |
|---|---|---|
| CHIESI USA, INC. IN-HOUSE | 25 | $2,800,000 |
| SPLITOAK STRATEGIES LLC | 13 | $570,000 |
| THE KPM GROUP DC LLC | 15 | $390,000 |
| THE CONAFAY GROUP, LLC | 5 | $90,000 |
| FTI GOVERNMENT AFFAIRS | 10 | $80,000 |
| Issue | Activities |
|---|---|
| Health Issues | 49 |
| Medicare/Medicaid | 12 |
| Pharmacy | 9 |
| Medical/Disease Research/Clinical Labs | 5 |